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Inhibition of DAF-2 (insulin-like growth factor 1
[IGF-1] receptor) or RSKS-1 (S6K), key molecules in
the insulin/IGF-1 signaling (IIS) and target of rapamy-
cin (TOR) pathways, respectively, extend lifespan in
Caenorhabditis elegans. However, it has not been
clear how and in which tissues they interact with
each other to modulate longevity. Here, we demon-
strate that a combination of mutations in daf-2 and
rsks-1 produces a nearly 5-fold increase in longevity
that is much greater than the sum of single muta-
tions. This synergistic lifespan extension requires
positive feedback regulation of DAF-16 (FOXO) via
the AMP-activated protein kinase (AMPK) complex.
Furthermore, we identify germline as the key tissue
for this synergistic longevity. Moreover, germline-
specific inhibition of rsks-1 activates DAF-16 in the
intestine. Together, our findings highlight the impor-
tance of the germline in the significantly increased
longevity produced by daf-2 rsks-1, which has
important implications for interactions between the
two major conserved longevity pathways in more
complex organisms.
INTRODUCTION
Aging can be modulated by both genetic and environmental
factors. Alterations in insulin/insulin-like growth factor 1 (IGF-1)
signaling (IIS), the target of rapamycin (TOR) pathway, signals
from the reproductive system, and dietary restriction (DR) signi-
ficantly affect lifespan (Kenyon, 2005, 2010). The highly
conserved TOR kinase serves as a nutrient sensor to promote
growth and proliferation via regulation of mRNA translation,1600 Cell Reports 5, 1600–1610, December 26, 2013 ª2013 The Autribosomal biogenesis, metabolism, and autophagy (Kapahi
et al., 2010; Wullschleger et al., 2006). TOR promotes mRNA
translation largely through the downstream ribosomal S6 kinase
(S6K) and translation initiation factor eIF-4E-binding protein
(4E-BP). Inhibition of TOR or S6K significantly extends lifespan
in multiple species (Hansen et al., 2007; Harrison et al., 2009;
Jia et al., 2004; Kaeberlein et al., 2005; Kapahi et al., 2004; Pan
et al., 2007; Vellai et al., 2003). The mechanisms overlap those
involved in DR, an environmental manipulation that extends life-
span and slows age-related pathologies (Kapahi et al., 2010).
rsks-1 encodes the Caenorhabditis elegans ortholog of S6K. In
addition to lifespan extension, rsks-1mutants also show delayed
development and reduced fertility (Hansen et al., 2007; Korta
et al., 2012; Pan et al., 2007; Selman et al., 2009). The longevity
phenotype of rsks-1 requires PHA-4, a FOXA transcription factor,
and AAK-2, a catalytic subunit of the 50 AMP kinase (AMPK)
(Selman et al., 2009; Sheaffer et al., 2008). AMPK is a key cellular
energy homeostasis regulator that is also partially required for
lifespan extension by reduced IIS (Apfeld et al., 2004).
Inhibition of IIS results in prolonged longevity in worms, flies,
mice, and probably humans (Clancy et al., 2001; Holzenberger
et al., 2003; Kenyon et al., 1993). In C. elegans, loss-of-function
mutations in daf-2, which encodes the insulin/IGF-1 receptor
homolog, lead to a more than doubled adult lifespan as well as
significant changes in development, metabolism, and increased
stress resistance (Gems et al., 1998; Kenyon et al., 1993; Kimura
et al., 1997). The significantly prolonged longevity of daf-2 is
totally dependent upon the downstream DAF-16 (FOXO) tran-
scription factor (Lin et al., 1997; Ogg et al., 1997). Functional
genomics studies have identified DAF-16 target genes that are
involved in stress response, metabolism, and detoxification
(Lee et al., 2003; McElwee et al., 2004; Murphy et al., 2003).
DAF-16 acts in specific tissues to modulate lifespan. Restoring
DAF-16 activity in the intestine (adipose tissue) substantially in-
creases the lifespan of daf-16; daf-2 double mutants (Libina
et al., 2003). On the other hand, DAF-16 functions throughhors
Figure 1. Double Mutations in daf-2 and rsks-1 Lead to Synergistically Prolonged Longevity that Requires DAF-16
(A) The daf-2 rsks-1 double mutant showed synergistically prolonged longevity (454% extension compared with N2) that was dependent on DAF-16.
(B) Inhibition of TOR by rapamycin led to increased lifespan extension in daf-2 compared with N2. Rapamycin (100 mM) extended N2 and daf-2 lifespan by 26%
and 45%, respectively (log rank, p < 0.0001). Animals treated with the vehicle (DMSO) alone did not show a significantly affected lifespan (log rank, p > 0.05).
Quantitative data and statistical analyses are included in Table S1.
(C) daf-2 rsks-1 animals showed significantly increased DAF-16 transcriptional activity. mRNA levels of DAF-16 targets that are either activated (sod-3 and
hsp-12.3) or inhibited (sams-1) by DAF-16 were quantified by qRT-PCR. Data are represented as mean ± SEM. Asterisks indicate statistical differences using
two-tailed t tests (***p < 0.001).
See also Figures S1 and S2.different factors to regulate the expression of downstream genes
both cell autonomously and nonautonomously (Zhang et al.,
2013). These findings suggest that IIS functions in an endo-
crine-like manner to modulate aging in C. elegans.
Signals from the reproductive system regulate lifespan in
worms, flies, and potentially mice (Flatt et al., 2008; Hsin and
Kenyon, 1999). In C. elegans, removal of the germline signifi-
cantly extends lifespan by activating DAF-16 in the intestine via
steroid hormone signaling (Berman and Kenyon, 2006; Hsin
and Kenyon, 1999). Lifespan extension by germline loss requires
DAF-16-mediated regulation of fat metabolism (McCormick
et al., 2012; O’Rourke et al., 2009; Wang et al., 2008) and protea-
some activity (Vilchez et al., 2012). Interestingly, removal of the
germline in certain daf-2 mutants synergistically enhances the
prolonged longevity phenotype, suggesting there might be reg-
ulatory interactions between IIS and signals from the reproduc-
tive system (Hsin and Kenyon, 1999).
Despite the well-characterized roles of daf-2 and rsks-1 in
aging and their apparently overlapping functions, it has not
been clear whether and how they might interact with each other
to affect longevity. To address this important question, we con-
structed a daf-2 rsks-1 double mutant, which displayed a syner-
gistic effect on longevity. The nearly 5-fold lifespan extension we
observed was mediated by positive feedback regulation of
DAF-16 via AMPK. Further analyses identified the germline asCell Rethe key tissue for RSKS-1, DAF-16, and AMPK to modulate the
synergistically prolonged longevity. Furthermore, inhibition of
rsks-1 in the germline nonautonomously activated DAF-16 in
the intestine. Collectively, our findings identify an interaction
between IIS and S6K in specific tissues that leads to a signifi-
cantly extended lifespan.
RESULTS
Synergistic Lifespan Extension by daf-2 rsks-1 Requires
DAF-16
To examine the genetic interaction between daf-2 and rsks-1, we
constructed a doublemutant that carries the daf-2(e1370) strong
loss-of-function allele and rsks-1(ok1255) deletion allele. The
double mutant is viable and fertile, and does not arrest at the
diapause dauer stage under standard culture conditions, which
allowed us to characterize the adult lifespan phenotypes. Since
the daf-2mutation is temperature sensitive, animals were grown
at a permissive temperature (15C or 20C) until the late L4 larval
stage and then transferred to a restrictive temperature (25C)
during adulthood for survival assays. The rsks-1 and daf-2 single
mutants increased themean lifespan by 20%and 169%, respec-
tively, whereas the daf-2 rsks-1 double mutant showed a syner-
gistic lifespan extension by 454% compared with the wild-type
N2 (Figure 1A; Table S1). This lifespan extension phenotypeports 5, 1600–1610, December 26, 2013 ª2013 The Authors 1601
was not due to unknown mutations in the background, since all
mutants were backcrossedwith the samewild-type N2 for amin-
imum of six times. Furthermore, similar lifespan extension phe-
notypes were observed with another deletion rsks-1(tm1714)
allele (Figure S1A), another point mutation daf-2(e1391) allele
(Figure S1B), or when animals were cultured at an intermediate
temperature (20C) throughout their life (Figure S1C). We also
performed lifespan assays with animals treated with rapamycin
to inhibit TOR, the upstream activator of RSKS-1. Rapamycin
mildly extended the lifespan of N2 by 26%, whereas it extended
the lifespan of the daf-2 mutant by 45% (Figure 1B).
The longevity phenotype of daf-2 is dependent on the down-
stream DAF-16 transcription factor (Lin et al., 1997; Ogg et al.,
1997). To test the role of DAF-16 in the daf-2 rsks-1-mediated
synergistic longevity, we constructed a daf-16; daf-2 rsks-1 triple
mutant using the daf-16(mgDf47) null allele. The daf-16 deletion
fully suppressed the prolonged longevity phenotype produced
by daf-2 rsks-1 (Figure 1A; Table S1). We then examined
DAF-16 transcriptional activity by performing quantitative
RT-PCR (qRT-PCR) to measure the mRNA levels of genes that
are regulated by DAF-16. sod-3 and hsp-12.3 are activated by
DAF-16, and sams-1 is repressed by DAF-16 at the transcription
level. Compared with daf-2, the daf-2 rsks-1 double mutant
showed a synergistic enhancement of DAF-16 transcription
activity as indicated by significantly increased expression of
sod-3 and hsp-12.3, and significantly decreased expression of
sams-1 (Figure 1C). Therefore, deletion of rsks-1 in daf-2 leads
to a synergistically extended lifespan by significantly increasing
DAF-16 activity.
Previous studies have identified transcription factors that are
essential for the prolonged longevity produced by the daf-2 or
rsks-1 single mutant. hsf-1 encodes the C. elegans heat-shock
transcription factor ortholog and is required for daf-2-mediated
lifespan extension (Hsu et al., 2003). Inhibition of hsf-1 by RNAi
decreased lifespan in all four of the genetic backgrounds tested
(Figure S2). hsf-1 inhibition suppressed the lifespan of daf-2
rsks-1 at a higher level (73%) than it did in other backgrounds
(40% in N2, 57% in rsks-1, and 65% in daf-2), and the lifespan
extension by daf-2 rsks-1 was almost completely suppressed
by the hsf-1 RNAi treatment (Figure S2). skn-1 encodes the Nrf
transcription factor ortholog that regulates oxidative stress
response. Mutations in skn-1 suppress lifespan extension by
certain daf-2 alleles (Tullet et al., 2008). However, inhibition of
skn-1 did not suppress the synergistic lifespan extension by
daf-2 rsks-1 (Figure S2D). pha-4 encodes a FOXA transcription
factor that is required for rsks-1 and DR-mediated lifespan
extension (Panowski et al., 2007; Sheaffer et al., 2008). Inhibition
of pha-4 shortened N2 and rsks-1 lifespan, but had no effect on
daf-2 lifespan (Figures S2A–S2C). Surprisingly, pha-4 knock-
down did not affect the lifespan of daf-2 rsks-1 (Figure S2D),
supporting the notion that the daf-2 rsks-1 double mutant ex-
tends lifespan by engaging different mechanisms compared
with the single mutants alone.
Effects of daf-2 rsks-1 on Development, Reproduction,
Stress Resistance, and DR
To further investigate the daf-2 rsks-1 mutant, we examined
other phenotypes associated with extended lifespan. In addi-1602 Cell Reports 5, 1600–1610, December 26, 2013 ª2013 The Auttion to prolonged longevity, mutations in daf-2 also affect
development, reproduction, and stress resistance. Under
harsh conditions, C. elegans may arrest development and
enter a diapause stage called dauer for extended survival
(Riddle and Albert, 1997). Inhibition of IIS leads to constitutive
dauer arrest in a temperature-sensitive manner, with complete
penetrance at a restrictive temperature of 25C. Some daf-2
animals transiently arrest as dauer larvae at the intermediate
temperature of 22.5C, which provides a condition to test
whether rsks-1 plays a role in IIS-dependent dauer formation.
We found that rsks-1 had no significant effect on daf-2 dauer
formation at 22.5C (Figure 2A), suggesting an uncoupling of
mechanisms for the synergistic longevity and dauer formation
in daf-2 rsks-1.
Previous studies have demonstrated that both daf-2 and
rsks-1 regulate germline proliferation and reproduction (Korta
et al., 2012; Michaelson et al., 2010). We examined the re-
production profiles of N2, rsks-1, daf-2, and daf-2 rsks-1. The
experiments were performed at 15C because at higher tem-
peratures, both daf-2 and daf-2 rsks-1 mutants show a high
incidence of embryo retention and thus internal hatching, which
leads to death and inaccurate measurement of reproduction.
We found that compared with daf-2, the daf-2 rsks-1 mutant
showed a delayed and prolonged reproduction period and
overall reduced brood size (Figure 2B). This is consistent with
recent studies showing that daf-2 and rsks-1 act in parallel to
regulate germline stem cell proliferation and differentiation
(Korta et al., 2012). The reproductive profile of daf-2 rsks-1
was similar to that of rsks-1, with slightly more severe pheno-
types. The lack of correlation between lifespan and reproduc-
tion suggests that the trade-off between longevity and fertility
is unlikely to be a major cause of the synergistic lifespan exten-
sion generated by daf-2 rsks-1.
The extended lifespan of daf-2 mutants has also been corre-
lated with the activation of stress response genes and increased
stress resistance (Murphy et al., 2003; Samuelson et al., 2007).
We performed various stress assays to determine whether the
synergistic longevity phenotype also correlates with increased
stress resistance. Surprisingly, we found that daf-2 rsks-1 ani-
mals were more sensitive to heat stress (35C), with the mean
survival decreased by 34% compared with the daf-2 single
mutant (Figure 2C). However, daf-2 rsks-1 animals were slightly
more resistant to oxidative stress induced by paraquat (Fig-
ure 2D) and UV stress (Figure 2E). Therefore, increased resis-
tance to stress may not be the main cause of the synergistic
longevity phenotype.
DR is a robust environmental manipulation that slows down
aging. Since both the IIS and TOR pathways are regulated by nu-
trients, we examined whether DR regulates the synergistic
longevity produced by daf-2 rsks-1 with the use of a modified
bacterial food deprivation DR regimen (DR-FD) (Kaeberlein
et al., 2006; Lee et al., 2006). Unlike animals growing under ad
libitum (AL) conditions, the rsks-1 single mutant under DR-FD
did not show a lifespan extension (log rank, p > 0.05). However,
the daf-2 rsks-1 double mutant still showed a robust lifespan
extension (by 114%) compared with daf-2 (Figure 2F), suggest-
ing that the synergistic longevity phenotype is not dependent on
nutrients.hors
Figure 2. Effects of daf-2 rsks-1 on Development, Reproduction, Stress Resistance, and DR
(A) rsks-1 did not affect daf-2 dauer formation at 22.5C. ns, not significant.
(B) daf-2 rsks-1 animals showed delayed, prolonged, and overall reduced reproduction. Data are represented as mean ± SEM.
(C) daf-2 rsks-1 animals were more sensitive to heat stress (35C) than daf-2 (log rank, p < 0.0001).
(D) daf-2 rsks-1 animals were more resistant to oxidative stress by paraquat compared with daf-2 (**p < 0.01, t test). Data are represented as mean ± SEM.
(E) daf-2 rsks-1 animals were more resistant to UV stress (2,000 J/m2) than daf-2 (log rank, p < 0.0001).
(F) daf-2 rsks-1 animals showed significantly increased survival under DR by bacterial food deprivation compared with daf-2 (log rank, p < 0.0001).Positive Feedback Regulation of DAF-16 via AMPK
Mediates the Synergistic Longevity Produced by daf-2
rsks-1
To characterize the molecular mechanisms of the synergistic
longevity produced by daf-2 rsks-1, we compared gene-
expression profiles in N2, rsks-1, daf-2, daf-2 rsks-1, and
daf-16; daf-2 rsks-1 by microarrays. Genes that are differen-
tially expressed in daf-2 rsks-1 to a greater extent than in
daf-2 in a DAF-16-dependent manner were chosen for analysis
(Figure 3A; Table S2). Gene Ontology (GO) analysis indicated
that ‘‘aging’’ and ‘‘determination of adult lifespan’’ are among
the most significant GO terms from this group of genes. We
chose 42 genes based on their expression patterns and identi-
ties to perform a genetic screen by RNAi to identify genes that
mediate the synergistic lifespan extension. We found 11 ge-
netic suppressors of daf-2 rsks-1, inhibition of which decreases
lifespan in daf-2 rsks-1 to a greater extent than in N2, rsks-1,
and daf-2 (Table S3).
aakg-4, which encodes the g regulatory subunit of AMPK,
showed the strongest suppression of daf-2 rsks-1 upon inhibi-
tion (Figure 3B; Table S1). In control RNAi-treated animals, the
daf-2 rsks-1 double mutant showed an 89% (synergistic)
lifespan extension compared with the daf-2 single mutant (Fig-
ure 3B, left panel). In aakg-4 RNAi-treated animals, daf-2 rsks-1
only showed an 18% (additive) lifespan extension compared
with daf-2 (Figure 3B, right panel). qRT-PCR experiments
confirmed that aakg-4 mRNA levels were further upregulatedCell Rein daf-2 rsks-1 (Figure S3A), and this regulation required
DAF-16 (Figure S3B). Since chromatin profiling studies by
DNA adenine methyltransferase identification (DamID) demon-
strated binding of DAF-16 to the aakg-4 promoter (Schuster
et al., 2010), aakg-4 is likely to be a direct target of DAF-16
that is critical for the synergistic longevity produced by daf-2
rsks-1. Consistently, a deletion in aak-2, which encodes the
a catalytic subunit of AMPK, also suppressed the synergistic
longevity (Figure 3C; Table S1). In the presence of aak-2, the
rsks-1 deletion synergistically extended the mean lifespan of
daf-2 by 85% (Figure 3C, left panel), whereas without aak-2,
rsks-1 only additively extended the mean lifespan of daf-2 by
18% (Figure 3C, right panel).
AMPK serves as an important energy homeostasis regulator
by activating catabolic pathways to promote ATP generation
upon energy starvation. It is a heterotrimer that consists of a cat-
alytic a subunit and regulatory b and g subunits. AMP competes
with ATP to bind the g subunit, which stimulates AMPK by keep-
ing the phosphorylation state of a highly conserved threonine in
the a subunit (Hardie, 2011). Consistent with previous studies
(Selman et al., 2009), the rsks-1 single mutant showed increased
AMPK activation, as indicated by elevated phosphorylation of
AAK-2 (Figure 3D). The daf-2 rsks-1 double mutant showed a
further increase in AAK-2 phosphorylation compared with the
rsks-1 single mutant (Figure 3D). This phenotype is AAKG-4-
dependent, as knockdown of aakg-4 significantly reduced
AAK-2 phosphorylation in daf-2 rsks-1 (Figure 3D). Previousports 5, 1600–1610, December 26, 2013 ª2013 The Authors 1603
Figure 3. The Synergistic Longevity Produced by daf-2 rsks-1 Is Mediated by Positive Feedback Regulation of DAF-16 via AMPK
(A) Genes that are differentially expressed in daf-2 rsks-1 were identified by microarray analyses.
(B) Identification of aakg-4 as a strong suppressor of daf-2 rsks-1. rsks-1-mediated lifespan extension in daf-2 (daf-2 versus daf-2 rsks-1): 89% in control RNAi and
18% in aakg-4 RNAi.
(C) A deletion in aak-2 suppressed the synergistic longevity produced by daf-2 rsks-1. rsks-1-mediated lifespan extension in daf-2 (daf-2 versus daf-2 rsks-1):
85% with aak-2 and 18% without aak-2. Quantitative data and statistical analyses are included in Table S1.
(D) The daf-2 rsks-1 double mutant showed further increased phosphorylation of AAK-2. Inhibition of aakg-4 significantly decreased AAK-2 phosphorylation in
daf-2 rsks-1. Data are represented as mean ± SEM.
(E) The aak-2 deletion suppressed the significantly increased DAF-16 transcriptional activity in daf-2 rsks-1. ***p < 0.001.
(F) Inhibition of aakg-4 in daf-2 rsks-1 reduced DAF-16 transcriptional activity. Data are represented as mean ± SEM. ***p < 0.001.
(G) Model depicting the synergistic lifespan extension through positive feedback regulation of DAF-16 via AMPK.
See also Figures S2 and S3, and Tables S2 and S3.studies demonstrated that AAK-2 directly phosphorylates and
activates DAF-16 in C. elegans (Greer et al., 2007). We found
that inhibition of AMPK either by aak-2 deletion or by aakg-4
RNAi blocked the significantly elevated DAF-16 transcriptional
activity in daf-2 rsks-1, as indicated by reduced mRNA levels of
hsp-12.3 and aakg-4 (Figures 3E and 3F). The fact that AAK-2
promotes the expression of its own activator, AAKG-4, suggests
a positive feedback mechanism. In the daf-2 rsks-1 double
mutant, AAK-2 is activated to increase DAF-16 activity, promot-
ing the expression of lifespan-determinant genes such as aakg-4,
which in turn further activates AAK-2 and DAF-16 to form a
positive feedback loop that eventually leads to significantly
increased DAF-16 activity and lifespan extension (Figure 3G).1604 Cell Reports 5, 1600–1610, December 26, 2013 ª2013 The AutTissue-Specific Regulation of the Synergistic Longevity
Produced by daf-2 rsks-1
In multiple cellular organisms, different tissues coordinately
modulate physiology and lifespan at the whole-organism level
in response to genetic and environmental manipulations. The
IIS pathway plays an endocrine role to modulate lifespan in a
cell-nonautonomous manner. Genetic mosaics lacking daf-2 in
neuronal precursor cells are long-lived (Apfeld and Kenyon,
1998), and neuronal expression of daf-2 rescues the daf-2
mutant-mediated lifespan extension (Wolkow et al., 2000). How-
ever, the essential IIS downstream transcription factor DAF-16
functions mainly in the intestine to modulate longevity (Libina
et al., 2003). Although RSKS-1 regulates many cellularhors
Figure 4. Tissue-Specific Regulation of the Synergistically Prolonged Longevity Produced by daf-2 rsks-1
(A) Mean lifespan extension by rsks-1 RNAi knockdown in different tissues of daf-2 animals. Data are represented as mean ± SEM.
(B) Changes in mean lifespan relative to control RNAi-treated animals by tissue-specific RNAi knockdown of daf-16, hsf-1, and aak-2 in daf-2 rsks-1. Data are
represented as mean ± SEM. Data from three independent experiments are shown. Survival curves are included in Figure S4. Quantitative data and statistical
analyses are included in Table S1.
See also Figure S6.processes globally, its tissue-specific role in lifespan determina-
tion has not been characterized. To better understand the
endocrine functions of daf-2 and rsks-1, we examined the tis-
sue-specific involvement of rsks-1, daf-16, hsf-1, and aak-2 in
daf-2 rsks-1-mediated synergistic longevity by tissue-specific
RNAi. RDE-1 is a member of the PIWI/STING/Argonaute family
of proteins, which are an essential component of the RNAi ma-
chinery (Tabara et al., 1999). Tissue-specific RNAi can be
achieved using transgenic rde-1 mutants complemented with
tissue-specific promoters that drive rde-1 cDNA expression
(Espelt et al., 2005; Qadota et al., 2007). Additionally, mutation
of rrf-1, which encodes an RNA-directed RNA polymerase,
allows RNAi to be functional exclusively in the germline but not
in somatic tissues (Sijen et al., 2001).
Using these tissue-specific RNAi tools, we identified the tis-
sues in which rsks-1 RNAi synergistically extended the lifespan
of daf-2 animals. Knockdown of rsks-1 in the daf-2 single mutant
extended themean lifespan by 54%.Germline- and hypodermis-
specific rsks-1 RNAi extended the daf-2 lifespan by 41% and
39%, respectively. Intestine-specific rsks-1 RNAi in daf-2
caused a moderate lifespan extension of 21%. Body wall mus-
cle-specific rsks-1 RNAi did not extend daf-2 lifespan signifi-
cantly (Figures 4A and S4; Table S1). Thus, rsks-1 loss of function
in the germline and hypodermis is likely to play an important role
in the synergistic longevity.
Next, we tested the tissue-specific involvement of the key sup-
pressors of daf-2 rsks-1, including daf-16, hsf-1, and aak-2.
Knockdown of daf-16, hsf-1, and aak-2 by RNAi in daf-2 rsks-1
suppressed the mean lifespan by 69%, 72%, and 58%, respec-
tively. Upon inhibition of these genes in the germline, the syner-
gistic longevity was significantly suppressed by daf-16 RNAi
(49%) and aak-2 RNAi (58%), but was only mildly affected by
hsf-1 RNAi (18%). Intestine-specific knockdown of daf-16,
hsf-1, and aak-2 significantly suppressed daf-2 rsks-1 lifespan
by 50%, 69%, and 39%, respectively. Additionally, inhibition of
daf-16 in the hypodermis also significantly decreased the daf-2
rsks-1 lifespan by 63%, whereas knockdown of aak-2 and
hsf-1 in the hypodermis moderately reduced the lifespan byCell Re35% and 36%, respectively. In the body wall muscle, knock-
down of daf-16, aak-2, and hsf-1 had little effect on longevity
(Figures 4B and S4; Table S1). In summary, it is likely that
DAF-16 functions in the germline, intestine, and hypodermis;
AAK-2 functions in the germline and intestine; and HSF-1 mainly
functions in the intestine to modulate the longevity of daf-2
rsks-1. These results demonstrate that in addition to the intes-
tine, other tissues, and especially the germline, also play an
important role in aging.
Germline SignalingModulates the Synergistic Longevity
Produced by daf-2 rsks-1
Previous studies have indicated that signals from the reproduc-
tive system modulate aging in multiple species. Signals from the
germline shorten lifespan, whereas signals from the somatic
gonad extend lifespan (Hsin and Kenyon, 1999). Prolonged
longevity via removal of germline precursor cells requires
DAF-16 and DAF-12 (nuclear hormone receptor). Hence, we
examined whether germline signaling modulates the synergistic
longevity produced by daf-2 rsks-1.
glp-1 encodes a Notch family receptor that is essential for
mitotic proliferation of germline cells (Austin and Kimble, 1987;
Priess et al., 1987). The long-lived glp-1 loss-of-function (lf)
mutant serves as a genetic mimic of germline removal. Similar
to the rsks-1 mutant, glp-1(lf) animals showed significantly
increased phosphorylation of AAK-2 (Figure S5A). Consistently,
inhibition of glp-1 by RNAi extended lifespan in N2, but not in
the aak-2 deletion mutant (Figure S5B). glp-1(ar202) is a gain-
of-function (gf) allele that exhibits germline overproliferation
and a shortened adult lifespan. We found that glp-1(gf) sup-
pressed the synergistic lifespan extension by daf-2 rsks-1.
Without glp-1(gf), the rsks-1 deletion synergistically extended
the mean lifespan of daf-2 by 86% (Figure 5A, left), whereas
with glp-1(gf), rsks-1 only additively extended the mean lifespan
of daf-2 by 14% (Figure 5A, right). Consistently, glp-1(gf) also
significantly decreased AAK-2 phosphorylation (Figure 5B) and
DAF-16 transcriptional activity (Figure 5C) in daf-2 rsks-1.
DAF-12, a nuclear hormone receptor, and KRI-1, an ankyrinports 5, 1600–1610, December 26, 2013 ª2013 The Authors 1605
Figure 5. Germline Signaling Modulates the daf-2 rsks-1-Mediated Synergistic Lifespan Extension through AMPK and DAF-16
(A) The glp-1(gf) mutation suppressed the synergistic longevity produced by daf-2 rsks-1. rsks-1-mediated lifespan extension in daf-2 (daf-2 versus daf-2 rsks-1):
86% without glp-1(gf) and 14% with glp-1(gf).
(B) The glp-1(gf) mutation decreased phosphorylation of AAK-2 in daf-2 rsks-1.
(C) The glp-1(gf) mutation suppressed the significantly increased DAF-16 transcriptional activity in daf-2 rsks-1. Data are represented as mean ± SEM.
***p < 0.001.
(D) Inhibition of DAF-12 or KRI-1, essential mediators of germline signaling, significantly suppressed the synergistic longevity produced by daf-2 rsks-1 (log rank,
p < 0.0001). Quantitative data and statistical analyses are included in Table S1.
See also Figure S5.repeats-containing protein, were identified as important regula-
tors of germline loss-mediated longevity (Berman and Kenyon,
2006; Hsin and Kenyon, 1999). Inhibition of daf-12 or kri-1 by
RNAi decreased the lifespan of daf-2 rsks-1 by 24% and 19%,
respectively (Figure 5D; Table S1). Altogether, these results sup-
port the idea that germline signals play an important role in daf-2
rsks-1-mediated activation of AMPK and DAF-16, and synergis-
tic lifespan extension.
Cell-Nonautonomous Activation of DAF-16 by
Knockdown of rsks-1 in the Germline
Since germline signaling has endocrine properties to regulate
DAF-16 cell-nonautonomously in the intestine (Berman and
Kenyon, 2006), we decided to examine whether inhibition of
rsks-1 in the germline affects downstream genes cell autono-
mously or nonautonomously. To answer this question, we
crossed an integrated gfp reporter driven by the stdh-1 pro-
moter (Pstdh-1::gfp) into daf-2 and daf-2; rrf-1 to examine
stdh-1 expression patterns upon rsks-1 RNAi treatment.
stdh-1 is transcriptionally activated by DAF-16. It is widely ex-
pressed in neurons, muscles, and intestine, allowing us to
monitor DAF-16 activities in various tissues. In the daf-2 back-
ground, rsks-1 RNAi activated stdh-1 expression in the intestine.
In daf-2; rrf-1, which allows RNAi to be functional only in the
germline, rsks-1 RNAi led to a significant induction of stdh-1
expression in the intestine (Figures 6A and 6B). To better quan-1606 Cell Reports 5, 1600–1610, December 26, 2013 ª2013 The Auttify the induction of Pstdh-1::gfp by rsks-1 RNAi, we performed
western blotting to measure GFP levels from whole worm ly-
sates, since the majority of the Pstdh-1::gfp expression was
from the intestine. Consistent with the imaging results, both reg-
ular and germline-specific rsks-1 RNAi increased Pstdh-1::gfp
expression (Figure 6C). We then quantified the intensities of
GFP bands relative to those of Actin, which serves as the internal
control for equal loading. The fold induction of Pstdh-1::gfp by
rsks-1 RNAi compared with the control RNAi was calculated.
Although the germline-specific RNAi mutant rrf-1 increased the
basal levels of stdh-1 expression, the induction of stdh-1
expression by rsks-1 RNAi was higher in daf-2 than in daf-2;
rrf-1 (Figure 6D). Thus, inhibition of rsks-1 in the germline nonau-
tonomously activates DAF-16 in the intestine.
DISCUSSION
IIS and TOR pathways play conserved roles in modulating life-
span in multiple species. However, it is unclear how they might
interactively modulate aging. We set out to address this question
by constructing a daf-2 rsks-1 double mutant, which has
reduced function of IIS and an important branch of the TOR
pathway. Surprisingly, the daf-2 rsks-1 double mutant showed
a nearly 5-fold lifespan extension (Figure 1A; Table S1). We
defined this phenotype as a synergistic lifespan extension,
based on the observation that the longevity of the daf-2 rsks-1hors
Figure 6. Cell-Nonautonomous Activation
of DAF-16 by rsks-1 RNAi Knockdown in
the Germline
(A) Activation of the DAF-16 target stdh-1 by rsks-1
RNAi in daf-2 and daf-2; rrf-1. rsks-1 RNAi
knockdown in the germline of daf-2 animals (daf-2;
rrf-1) significantly increased the intestinal expres-
sion of GFP driven by the stdh-1 promoter. Arrows
indicate the anterior and posterior intestines.
(B) Quantification of GFP expression driven by the
stdh-1 promoter. Thirty animals were examined for
each treatment.
(C) Measurement of Pstdh-1::gfp expression by
western blots with anti-GFP.
(D) Quantification of GFP expression from western
blots. Relative GFP levels were calculated by
normalizing the intensities of GFP bands to Actin.
The fold increase in Pstdh-1::gfp expression
induced by rsks-1RNAi was calculated by dividing
the relative GFP levels in rsks-1 RNAi-treated an-
imals by those in control RNAi-treated animals.
Data are represented as mean ± SEM. **p < 0.01.
The quantification was performed with four bio-
logical replicates.double mutant is beyond the combined effects of rsks-1 and
daf-2 single mutants. This synergistic longevity phenotype
cannot be explained by the hypothesis that daf-2 and rsks-1
function in parallel to modulate lifespan independently, since
an additive effect would be expected under such an assumption.
The synergistic longevity phenotype is different from what we
previously reported; i.e., that rsks-1 RNAi further extended the
daf-2 lifespan by 24% (Pan et al., 2007). One major difference
in the experimental procedures used is that in the previous study,
daf-2 animals were treated with rsks-1 RNAi only during adult-
hood, whereas in the current work, we used a double mutant
that carries the putative null allele of rsks-1 throughout life.
When we treated daf-2 animals with rsks-1 RNAi for two gener-
ations, resulting in a more complete reduction in rsks-1 mRNA
levels, we observed a 54% further lifespan extension (Fig-
ure S4A; Table S1). These results suggest that inhibition of
rsks-1 during development is critical for the synergistic longevity
phenotype. Consistently, inhibition of the RSKS-1 upstream acti-
vator LET-363/CeTOR in daf-2 during adulthood led to a 17%
additive lifespan extension (Figure S6). Since let-363 is an essen-
tial gene, inhibition of which during development leads to larval
arrest, we used a pharmaceutical approach to inhibit let-363
by treating animals with rapamycin as previously reported (Ro-
bida-Stubbs et al., 2012). Rapamycin treatment throughout life
extended the lifespan of N2 and daf-2 animals by 26% and
45%, respectively (Figure 1B). There are multiple possible rea-
sons why rapamycin treatment could not extend the lifespan of
daf-2 animals as much as the rsks-1 deletion mutant did. One
possibility is that rapamycin treatment did not fully block
RSKS-1, which is required for the synergistic longevity. Another
possibility is that since rapamycin treatment at this dosage has
been shown to inhibit both TOR complex 1 and complex 2 activ-
ities (Robida-Stubbs et al., 2012), the drugmight also affect other
lifespan-determinant genes. Nevertheless, these results are
consistent with the idea that inhibiting rsks-1 in daf-2 during
development leads to a synergistic lifespan extension.Cell RePrevious studies showed that null mutants of age-1, which en-
codes a catalytic subunit of the phosphatidylinositol-3-kinase
(PI3K) in the IIS pathway, exhibit an exceptional lifespan exten-
sion in a DAF-16-dependent manner (Ayyadevara et al., 2008).
Since the daf-2 mutations we used in this study are not null al-
leles, one possible explanation for the synergistic longevity pro-
duced by daf-2 rsks-1 is that the rsks-1 deletion makes daf-2
mutant phenotypes more severe. We think this is unlikely to be
true, because many aging-related phenotypes of daf-2 are not
enhanced by the rsks-1 deletion. As shown in Figure 2, rsks-1
does not affect daf-2-mediated dauer arrest, and rsks-1 has a
minor or even opposite effect on most stress resistance. Under-
standing why these phenotypes are uncoupled from the syner-
gistically prolonged longevity produced by daf-2 rsks-1 will
help to elucidate the basic mechanisms of aging.
TORplays a conserved role in DR-mediated lifespan extension
(Kapahi et al., 2010). We tested the effect of nutrients on the
synergistic longevity using the DR-FD regimen (Figure 2F). The
rsks-1 single mutant did not show a lifespan extension under
DR, which is consistent with the idea that DR and reduced
TOR signaling function through overlapping mechanisms to
extend lifespan. Interestingly, the synergistic longevity produced
by daf-2 rsks-1 is nutrient independent, suggesting that rsks-1
functions through unidentified mechanisms to further extend
the lifespan of daf-2 animals.
To better understand the molecular mechanisms of the syner-
gistic longevity produced by daf-2 rsks-1, we set out to identify
critical mediators by testing known regulators of IIS or rsks-1.
Heat-shock factor 1 (HSF-1) is critical for daf-2-mediated life-
span extension. Inhibition of hsf-1 almost completely abolished
the lifespan extension produced by daf-2 rsks-1 (Figure S2). Life-
span extension via genetic or pharmaceutical inhibition of TOR
requires the IIS downstream transcription factor SKN-1 (Ro-
bida-Stubbs et al., 2012). Surprisingly, inhibition of skn-1 by
RNAi had little effect on the synergistic longevity produced by
daf-2 rsks-1 (Figure S2). Similarly, inhibition of PHA-4, a FOXAports 5, 1600–1610, December 26, 2013 ª2013 The Authors 1607
transcription factor that is required for the rsks-1 single mutant-
mediated lifespan extension, did not affect the lifespan of daf-2
rsks-1 (Figure S2). This is further evidence that the mechanism
of the synergistic longevity in the daf-2 rsks-1 double mutant is
distinct from the lifespan extension caused by the single
mutants.
We then performed microarray studies and identified genes
that are differentially expressed in daf-2 rsks-1 (Figure 3A; Table
S2). A genetic screen using RNAi helped us identify the AMPK
complex as the key mediator of the synergistic longevity pro-
duced by daf-2 rsks-1 (Figures 3B and 3C; Tables S1 and S3).
Quantitative analysis of the lifespan data indicated that suppres-
sion of the daf-2 rsks-1 lifespan by inhibition of AMPK was not
due to general sickness. Instead, inhibition of AMPK suppressed
the synergy part of the lifespan extension. Further analysis iden-
tified a positive feedback regulation of DAF-16 via AMPK in the
daf-2 rsks-1 mutant (Figures 3D–3G). AMPK plays important
roles in various cellular functions (Hardie, 2011). Under energy-
starved conditions, AMPK is activated to promote catabolism
and thus ATP production. Further characterization of the role
of AMPK in metabolism will enhance our understanding of the
synergistic longevity produced by daf-2 rsks-1.
Both IIS and signals from the reproductive system have endo-
crine functions. Modulation of these pathways in one tissue
leads to nonautonomous activation of DAF-16 in the intestine
(Berman and Kenyon, 2006; Libina et al., 2003). To better under-
stand how aging is coordinately modulated across multiple tis-
sues, we tested the involvement of key regulators of the daf-2
rsks-1-mediated synergistic longevity by tissue-specific RNAi.
We found that rsks-1, daf-16, and aak-2 function in the germline
to regulate the synergistic lifespan extension (Figure 4), which
can also be suppressed by a genetic mutation that causes germ-
line overproliferation or by inhibition of key mediators of germline
signaling (Figure 5). In addition, inhibiting rsks-1 in the germline
leads to nonautonomous activation of DAF-16 in the intestine
(Figure 6). Previous studies on the tissue-specific requirements
of key longevity determinants, including DAF-16, mainly em-
ployed transgenic rescue approaches. However, the traditional
microinjection method creates transgenic lines with a high
copy number of transgenes, which will be silenced in the germ-
line. Our results indicate that the germline is an important tissue
for integrating signals from the IIS pathway and S6K for lifespan
determination.
Similar to the rsks-1 single mutant, daf-2 rsks-1 animals
showed significantly delayed, prolonged, and overall reduced
reproduction (Figure 2B). This is consistent with a recent study
showing that RSKS-1 acts in parallel with the IIS pathway to
play an essential role in establishing the germline stem cell/pro-
genitor pool (Korta et al., 2012). Interestingly, RSKS-1 functions
cell autonomously to regulate establishment of the germline pro-
genitor. This effect is independent of its known suppressors in
the regulation of lifespan (Korta et al., 2012). These findings sug-
gest that the synergistic longevity of daf-2 rsks-1 cannot simply
be linked with its functions in germline development and
reproduction.
In C. elegans, the intestine carries out multiple nutrient-related
functions and is the site for food digestion and absorption, fat
storage, and immune response. DAF-16 is one of the essential1608 Cell Reports 5, 1600–1610, December 26, 2013 ª2013 The Auttranscription factors that function in the intestine to modulate
lifespan. We found that intestinal-specific inhibition of daf-16,
aak-2, or hsf-1 largely abolishes the synergistic lifespan exten-
sion of daf-2 rsks-1 (Figure 4B). However, knockdown of rsks-1
in the intestine only has an additive effect on daf-2 lifespan
(Figure 4A), suggesting that rsks-1may function through nonau-
tonomous mechanisms to activate DAF-16.
The hypodermis is considered as part of the epithelial system
inC. elegans. It is involved in basic body plan establishment, cell
fate specification, axon migration, apoptotic cells removal, and
fat storage. We found that hypodermis-specific knockdown of
rsks-1 in daf-2 also leads to synergistic lifespan extension, and
that hypodermis-specific knockdown of daf-16 significantly re-
duces the synergistic lifespan extension (Figure 4). Our results
provide evidence for the important role of the hypodermis in life-
span determination. In future studies, it will be interesting to
examine which biological functions of the hypodermis are
involved in regulating the synergistic longevity by daf-2 rsks-1.
Previous studies showed that muscle decline is one of the ma-
jor physiological causes of aging in C. elegans (Herndon et al.,
2002). Neither rsks-1 nor the downstream regulators daf-16,
hsf-1, and aak-2 seem to function in the muscle to modulate
the synergistic lifespan extension (Figure 4). However, we cannot
rule out the possibility that these regulators may function in other
tissues to nonautonomously regulate muscle functions in daf-2
rsks-1. Characterization of age-dependent muscle decline in
daf-2 rsks-1 will help to elucidate whether muscle functions are
important for the synergistic lifespan extension.
There are limitations to assessing tissue-specific involvement
of key regulators in lifespan determination by RNAi, such as un-
certainty of knockdown efficiency and potential leakiness. It has
been reported that in rrf-1 mutants, RNAi can be processed in
certain somatic tissues, including the intestine, at least for the
genes tested (Kumsta and Hansen, 2012). However, the critical
function of rsks-1 in the germline is unlikely to be an artifact, as
rsks-1 knockdown in the intestine of daf-2 animals did not lead
to synergistic lifespan extension. Moreover, inhibition of certain
strong suppressors of daf-2 rsks-1 (e.g., hsf-1) in the intestine,
but not in the germline, significantly decreased the synergistic
lifespan extension produced by daf-2 rsks-1. Further analyses
with single-copied, isoform-specific transgenic rescue will help
to quantitatively determine the tissue-specific involvement of
key regulators in the synergistic lifespan extension produced
by daf-2 rsks-1.
It has not been clear whether DAF-16 is quantitatively more
active or is uniquely activated in certain tissues, such as the
germline of daf-2 rsks-1. Although we identified the AMPK-medi-
ated positive feedback regulation of DAF-16 based on genes that
are expressed to a greater extent in daf-2 rsks-1 animals, we
speculate that the double mutant has some unique properties,
as shown in dauer formation and various stress-tolerance as-
says. Our data from the phenotypic analysis of the doublemutant
and epistasis analysis of tissue requirement of DAF-16 suggest
that with the rsks-1 deletion, DAF-16 plays a more important
role in certain tissues, such as the germline, to further extend
the lifespan of daf-2. Characterization of the genes that are
uniquely upregulated in daf-2 rsks-1 or those that are regulated
independently of DAF-16 will help distinguish these models.hors
In conclusion, we found that the daf-2 rsks-1 double mutant
shows a synergistic lifespan extension, which is achieved
through positive feedback regulation of DAF-16 by AMPK. Tis-
sue-specific epistasis analysis suggests that this enhanced acti-
vation of DAF-16 is initiated by signals from the germline, and
that the germline tissue may play a key role in integrating the in-
teractions between daf-2 and rsks-1 to cause a synergistic life-
span extension. Since DAF-2, RSKS-1, AMPK, and DAF-16 are
highly conserved molecules, similar regulation may also exist
in mammals. Further characterization of the daf-2 rsks-1-medi-
ated synergistic longevity will contribute to a better understand-
ing of the molecular mechanisms of aging and age-related
diseases.
EXPERIMENTAL PROCEDURES
Lifespan Assays
Animals were maintained at 15C or 20C until late L4 stages and then trans-
ferred to 25C. The first day of adulthood is day 1 in survival curves. Animals
were scored as alive, dead, or lost every 2–3 days.
qRT-PCR Assays
The SYBR Green dye (Quanta) was used for qRT-PCR reactions performed
on an LC480 machine (Roche). Relative fold changes were calculated using
the 2DDCt method (Livak and Schmittgen, 2001). qRT-PCR experiments
were performed three times, with consistent results, using three independent
RNA preparations.
Microarray Analysis
Microarray hybridization was performed at the Buck Institute Genomics Core
using the NimbleGen 12-Plex Gene Expression Arrays and arrays were quan-
tified using the NimbleScan2 software.
Western Blotting
Western blotting for phosphorylated AAK-2 (1:300; Cell Signaling), Actin
(1:1,000; Cell Signaling), and GFP (1:1,000; UC Davis/NIH NeuroMab Facility)
were performed with the LICOR system. Band intensities were quantified with
Odyssey V3.0 software.
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